Teva inks biggest deal in Israeli pharmaceutical industry’s history
(Israel Hayom/Exclusive to JNS.org) Israeli pharmaceutical giant Teva announced Tuesday that it has finalized its acquisition of Dublin-based Allergan’s Actavis Global Generics for $40.5 billion. This is the biggest acquisition deal in the Israeli pharmaceutical industry’s history.
As part of the deal, Teva Pharmaceutical Industries acquired Actavis Global Generics’ with its U.S. and international generic commercial units, third-party supplier Medis, global generic manufacturing operations, and the global generic research and development unit as well as Allergan’s international over-the-counter commercial unit and certain established international brands, an Allergan press release said.
Allergan is a global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.
The deal means Teva will have 338 products awaiting FDA approval, including 115 products with a first-submit option — a substantial commercial advantage in the global pharmaceutical industry.
Teva recently released a study showing the generic drugs it produces generated savings of about $215 billion to the U.S. healthcare system over the last decade.
“The acquisition of Actavis Global Generics will help us build a new Teva, one with a more solid foundation, upgraded financial profile and more diverse revenue and profit sources,” Teva President and CEO Erez Vigodman said.
*
Israelis score silver, bronze medals at International Chemistry Olympiad
Ron Solan, a student at Rishonim High School in Herzliya, captured the silver, while Rina Sevostianov, a student at the Mekif Gimmel High School in Ashdod, took home a bronze medal. The team trained for the competition at the Schulich Faculty of Chemistry at the Technion-Israel Institute of Technology.
A total of 66 countries sent teams to the International Chemistry Olympiad. Israel ranked 20th overall, and second among the Western nations that participated, after the U.S. The Romanian team won first place overall, followed by China in both second and third place.
“Time and again, Israeli students bring honor and pride to Israel in international science competitions,” Education Minister Naftali Bennett said Tuesday.
*
IDF testing augmented reality technology
The HoloLens is an Augmented Reality (AR) device, which the IDF wants to use for training and for conceptualizing enemy territory using holographic images.
“We understand that in the fast world in which we live, with an emphasis on the technology aspect, the only constant is the element of change. If we fight the next war like we fought the previous one, if we use the same technology that was right for that war, then it likely won’t be easy for us to win,” Maj. Rotem Bashi, chief programmer at the IDF’s telecommunications and information technology unit, told Israel’sChannel 10.
Trump to campaign in Israel for expat votes
Trump will appoint Israeli campaign staff by this weekend, and will begin working on the campaign in the coming days, the Israeli channel reported. Trump also plans to visit Israel during his presidential campaign against democratic rival Hillary Clinton.
Israeli Prime Minister Benjamin Netanyahu has said he does not plan to endorse either presidential candidate.
*
Articles from JNS.org appear on San Diego Jewish World through the generosity of Dr. Bob and Mao Shillman. Comments intended for publication in the space below MUST be accompanied by the letter writer’s first and last name and by his/ her city and state of residence (city and country for those outside the United States.)